Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 98

Similar articles for PubMed (Select 23539050)

1.

Is a legacy effect possible in IgA nephropathy?

Coppo R.

Nephrol Dial Transplant. 2013 Jul;28(7):1657-62. doi: 10.1093/ndt/gft016. Epub 2013 Mar 28. Review.

PMID:
23539050
2.
3.

Tonsillectomy has beneficial effects on remission and progression of IgA nephropathy independent of steroid therapy.

Maeda I, Hayashi T, Sato KK, Shibata MO, Hamada M, Kishida M, Kitabayashi C, Morikawa T, Okada N, Okumura M, Konishi M, Konishi Y, Endo G, Imanishi M.

Nephrol Dial Transplant. 2012 Jul;27(7):2806-13. doi: 10.1093/ndt/gfs053. Epub 2012 Apr 5.

4.
5.

Effect of tonsillectomy plus steroid pulse therapy on clinical remission of IgA nephropathy: a controlled study.

Komatsu H, Fujimoto S, Hara S, Sato Y, Yamada K, Kitamura K.

Clin J Am Soc Nephrol. 2008 Sep;3(5):1301-7. doi: 10.2215/CJN.00310108. Epub 2008 May 28.

6.

Steroid and cyclophosphamide in IgA nephropathy.

Roccatello D, Ferro M, Cesano G, Rossi D, Berutti S, Salomone M, Piccoli G, Sena LM.

Nephrol Dial Transplant. 2000 Jun;15(6):833-5.

7.

ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.

Haas M, Jafri J, Bartosh SM, Karp SL, Adler SG, Meehan SM.

Am J Kidney Dis. 2000 Oct;36(4):709-18.

PMID:
11007672
8.

Non-immunosuppressive treatment for IgA nephropathy.

Reid S, Cawthon PM, Craig JC, Samuels JA, Molony DA, Strippoli GF.

Cochrane Database Syst Rev. 2011 Mar 16;(3):CD003962. doi: 10.1002/14651858.CD003962.pub2. Review.

PMID:
21412884
9.

Clinical and cost-effectiveness of newer immunosuppressive regimens in renal transplantation: a systematic review and modelling study.

Woodroffe R, Yao GL, Meads C, Bayliss S, Ready A, Raftery J, Taylor RS.

Health Technol Assess. 2005 May;9(21):1-179, iii-iv. Review.

10.

Therapy of IgA nephropathy with mycophenolate mofetil--report of 3 cases.

Bergner R, Hoffmann M, Brass H, Uppenkamp M.

Clin Nephrol. 2004 Mar;61(3):207-12.

PMID:
15077872
11.

Immune modulating therapy for IgA nephropathy: rationale and evidence.

Floege J, Eitner F.

Semin Nephrol. 2008 Jan;28(1):38-47. doi: 10.1016/j.semnephrol.2007.10.005. Review.

PMID:
18222345
12.

IgA nephropathy with severe chronic renal failure: a randomized controlled trial of corticosteroids and azathioprine.

Pozzi C, Andrulli S, Pani A, Scaini P, Roccatello D, Fogazzi G, Pecchini P, Rustichelli R, Finocchiaro P, Del Vecchio L, Locatelli F.

J Nephrol. 2013 Jan-Feb;26(1):86-93. doi: 10.5301/jn.5000110.

PMID:
22460183
13.
14.

Treatment of immunoglobulin A nephropathy.

Schiele J, Nowack R, Julian BA, van der Woude FJ.

Ann Med Interne (Paris). 1999 Feb;150(2):127-36. Review.

PMID:
10392261
15.

Tonsillectomy and steroid pulse therapy significantly impact on clinical remission in patients with IgA nephropathy.

Hotta O, Miyazaki M, Furuta T, Tomioka S, Chiba S, Horigome I, Abe K, Taguma Y.

Am J Kidney Dis. 2001 Oct;38(4):736-43.

PMID:
11576876
16.

Long-term results of a randomized controlled trial in childhood IgA nephropathy.

Kamei K, Nakanishi K, Ito S, Saito M, Sako M, Ishikura K, Hataya H, Honda M, Iijima K, Yoshikawa N; Japanese Pediatric IgA Nephropathy Treatment Study Group.

Clin J Am Soc Nephrol. 2011 Jun;6(6):1301-7. doi: 10.2215/CJN.08630910. Epub 2011 Apr 14.

17.

Tonsillectomy with methylprednisolone pulse therapy as rescue treatment for steroid-resistant IgA nephropathy in children.

Kawasaki Y, Suyama K, Abe Y, Ushijima Y, Sakai N, Takano K, Ito M, Hashimoto K, Hosoya M.

Tohoku J Exp Med. 2009 May;218(1):11-6.

18.

Efficacy of methylprednisolone, cyclophosphamide in pediatric IgA nephropathy assessed by renal biopsy.

Jiang XY, Mo Y, Sun LZ, Yue ZH, Chen SM, Wu W.

Clin Nephrol. 2009 Jun;71(6):625-31.

PMID:
19473630
19.

Comparison of antiproteinuric effects of two different combination therapies in children with IgA nephropathy.

Yagi K, Okada M, Yanagida H, Kuwajima H, Ikeda M, Sugimoto K, Takemura T.

Clin Exp Nephrol. 2003 Dec;7(4):270-4.

PMID:
14712355
20.

Tonsillectomy with steroid pulse therapy has more effect on the relapse rate than steroid pulse monotherapy in IgA nephropathy patients.

Ohya M, Otani H, Minami Y, Yamanaka S, Mima T, Negi S, Yukawa S, Shigematsu T.

Clin Nephrol. 2013 Jul;80(1):47-52. doi: 10.5414/CN107861.

PMID:
23557791
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk